• Vivozon Holdings kept its stake in Vivozon Pharmaceutical unchanged at 19,409,481 shares, or 31.25%, as of Oct. 6.
• Shares subject to major contracts fell to 13,706,968 shares, or 22.07%, from 14,962,072 shares, or 24.09%.
• Changes reflected partial loan repayment releasing pledged shares, contract releases tied to an exchangeable bond redemption, new collateral for a fourth exchangeable bond.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vivozon Pharmaceutical Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261006000325), on October 06, 2026, and is solely responsible for the information contained therein.